Julie Mark, MD
NPI 1518927482 · Dermatology Physician · Akron, OH
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Julie Mark, MD is a Dermatology Physician provider in Akron, OH (NPI 1518927482).
Provider details
- NPI number
- 1518927482
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 35073333 (OH)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
291 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 122 | $121 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 54 | $6 |
| Biopsy of Related Skin Growth, First Growth11102 | 35 | $90 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 29 | $53 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 23 | $86 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 37 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Clobetasol Propionate | 174 | 49 |
| Triamcinolone Acetonide | 121 | 57 |
| Ketoconazole | 115 | 31 |
| Apremilastbrand: Otezla | 101 | 12 |
| Dupilumabbrand: Dupixent Pen | 84 | 11 |
| Clindamycin Phosphate | 62 | 12 |
| Ciclopirox | 60 | 12 |
| Acitretin |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$190 across 10 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-24
- Last updated
- 2011-09-21
Frequently asked questions
- What is Julie Mark's NPI number?
- Julie Mark's National Provider Identifier (NPI) is 1518927482, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Julie Mark's specialty?
- Julie Mark is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Julie Mark located?
- Julie Mark's practice location on file with NPPES is One Park West Blvd., Akron, OH 44320.
- What is Julie Mark's phone number?
- The practice phone number listed in the NPPES registry for Julie Mark is (330) 835-9158.
- Does Julie Mark accept Medicare?
- Julie Mark is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Julie Mark's NPI active?
- Yes — Julie Mark's NPI (1518927482) is active in the NPPES registry as of the last update on 2011-09-21.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.